Agenus Inc's Form 4 filing
MiNK Therapeutics, Inc. (INKT) · filed Oct 6, 2023
- Accession no.
- 0000950170-23-052408
- Filed
- Oct 6, 2023
- Trade date
- Oct 4, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market purchases total $16.4K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Agenus IncCIK 0001098972 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 4, 2023 | Common Stock | PPurchaseAcquired | +15,001 | $1.09 | +$16,351.09 | 21,749,888 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.